Viewing Study NCT02154308


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-01-13 @ 5:25 PM
Study NCT ID: NCT02154308
Status: COMPLETED
Last Update Posted: 2014-06-03
First Post: 2014-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults
Sponsor: Il-Yang Pharm. Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module